GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 276 filers reported holding GW PHARMACEUTICALS PLC in Q3 2018. The put-call ratio across all filers is 1.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $104,000 | -20.6% | 1,073 | -0.2% | 0.01% | -26.3% |
| Q2 2020 | $131,000 | +70.1% | 1,075 | +22.9% | 0.02% | +26.7% |
| Q1 2020 | $77,000 | -48.7% | 875 | -38.9% | 0.02% | -42.3% |
| Q4 2019 | $150,000 | +11.9% | 1,433 | +23.0% | 0.03% | 0.0% |
| Q3 2019 | $134,000 | -31.3% | 1,165 | +2.6% | 0.03% | -35.0% |
| Q2 2019 | $195,000 | +5.4% | 1,135 | +2.9% | 0.04% | +5.3% |
| Q1 2019 | $185,000 | +74.5% | 1,103 | +0.6% | 0.04% | +46.2% |
| Q4 2018 | $106,000 | -41.8% | 1,096 | +0.7% | 0.03% | -23.5% |
| Q3 2018 | $182,000 | +67.0% | 1,088 | +38.1% | 0.03% | +54.5% |
| Q2 2018 | $109,000 | – | 788 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 602,047 | $61,102,000 | 6.76% |
| FT Options LLC | 36,847 | $3,740,000 | 5.64% |
| SCOPIA CAPITAL MANAGEMENT LP | 2,988,019 | $303,254,000 | 4.80% |
| FT Options LLC | 71,000 | $1,320,000 | 1.99% |
| Rock Springs Capital Management LP | 373,000 | $37,856,000 | 1.75% |
| Redmile Group, LLC | 338,536 | $34,358,000 | 1.70% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 362,724 | $36,813,000 | 1.66% |
| Ghost Tree Capital, LLC | 50,000 | $5,075,000 | 1.08% |
| Atika Capital Management LLC | 32,500 | $3,298,000 | 0.95% |
| Sivik Global Healthcare LLC | 25,000 | $2,537,000 | 0.86% |